Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 6;22(1):207.
doi: 10.1186/s12886-022-02425-8.

Impact of keratoconus stage on outcome after corneal crosslinking

Affiliations

Impact of keratoconus stage on outcome after corneal crosslinking

Caroline Julia Gassel et al. BMC Ophthalmol. .

Abstract

Background: This study aimed to analyze if the outcome after corneal crosslinking (CXL) in progressive keratoconus patients depends on the stage at which the procedure is performed. This knowledge would help to improve success of CXL and to define surgery indications in those patients.

Methods: In this retrospective study, 124 consecutive eyes of 100 patients with progressive keratoconus undergoing corneal CXL at the University Eye Hospital Tübingen were included. The eyes were graded according to modified Krumeich stages depending on induced myopia or astigmatism, corneal radii, minimum corneal thickness, and morphological changes. The observation period covered November 2008 to September 2018. Preoperatively, 12 and 24 months after CXL, the best corrected visual acuity (BCVA) was determined and astigmatism as well as tomographic parameters (Kmax, Kmin, central corneal thickness (CCT), minimum corneal thickness (MCT)) were measured by means of a Scheimpflug camera system.

Results: BCVA results showed significant differences between the modified Krumeich stages at 12 months (p = 0.014) and at 24 months postoperatively (p = 0.032). Also, astigmatism differed significantly among the stages at 24 months after CXL (p = 0.023). However, no significant differences regarding astigmatism were detectable after 12 months. In terms of Kmax, Kmin, CCT, and MCT, no significant differences between the Krumeich stages were observed.

Conclusions: BCVA showed a significantly higher improvement after CXL in the early stage of keratoconus compared to a higher stage. However, the postinterventional tomographic values did not differ significantly between the different modified Krumeich stages. The significantly higher improvement in BCVA after CXL in the early stage might indicate that earlier intervention provides a higher subjective benefit to the individual. Further studies with larger sample sizes are needed to confirm these findings.

Keywords: CXL; Corneal crosslinking; Crosslinking; Keratoconus; Krumeich.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
BCVA and tomographic parameters depending on the three groups. Data presented as mean ± SD preoperatively and 12 and 24 months following corneal CXL. a) BCVA, b) astigmatism, c) Kmax, d) Kmin, e) MCT, f) CCT. Statistically significant group differences (*p < 0.05) were observed for BCVA (12 months and 24 months post-op) and astigmatism (24 months post-op)

References

    1. Krumeich JH, Daniel J, Knulle A. Live-epikeratophakia for keratoconus. J Cataract Refract Surg. 1998;24(4):456–463. doi: 10.1016/S0886-3350(98)80284-8. - DOI - PubMed
    1. Krumeich JH, Daniel J. Live epikeratophakia and deep lamellar keratoplasty for I-III stage-specific surgical treatment of keratoconus. Klin Monatsbl Augenheilkd. 1997;211(2):94–100. doi: 10.1055/s-2008-1035103. - DOI - PubMed
    1. Downie LE, Lindsay RG. Contact lens management of keratoconus. Clin Exp Optom. 2015;98(4):299–311. doi: 10.1111/cxo.12300. - DOI - PubMed
    1. Parker JS, van Dijk K, Melles GR. Treatment options for advanced keratoconus: a review. Surv Ophthalmol. 2015;60(5):459–480. doi: 10.1016/j.survophthal.2015.02.004. - DOI - PubMed
    1. Andreanos KD, Hashemi K, Petrelli M, Droutsas K, Georgalas I, Kymionis GD. Keratoconus treatment algorithm. Ophthalmol Therapy. 2017;6(2):245–262. doi: 10.1007/s40123-017-0099-1. - DOI - PMC - PubMed

LinkOut - more resources